NRSN
Neurosense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.99
−6.57%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.42x
- Price / sales
- —
- Price / cash flow
- -1.03x
Enterprise value
- Enterprise value
- $3.8M
- EV / sales
- —
- EV / EBITDA
- -0.34x
- EV / EBIT
- -0.34x
- Market cap
- $3.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025